Megan Knight

Investor Relations Contact bei ARENA PHARMACEUTICALS

Health Technology

Consumer Non-Durables

Aktive Positionen von Megan Knight

Unternehmen	Position	Beginn	Ende
ARENA PHARMACEUTICALS	Investor Relations Contact	-	-
LONGBOARD PHARMACEUTICALS, INC.	Investor Relations Contact	01.01.2021	-

Unternehmen	Position	Beginn	Ende
SENOMYX INC.	Investor Relations Contact	-	-
SENOMYX INC.	Public Communications Contact	-	-

International

Vereinigte Staaten

Operativ

Investor Relations Contact	3
Public Communications Contact	1

Sektoral

Health Technology	3
Consumer Non-Durables	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
LONGBOARD PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT.	Health Technology
Senomyx, Inc. Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA.	Consumer Non-Durables

Private Unternehmen

Health Technology

Consumer Non-Durables